THE ANALYSIS OF COSTS AND REIMBURSEMENTS FOR LUNG CANCER TREATMENT IN THE CZECH REPUBLIC
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F13%3A00208462" target="_blank" >RIV/68407700:21460/13:00208462 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.jval.2013.08.483" target="_blank" >http://dx.doi.org/10.1016/j.jval.2013.08.483</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jval.2013.08.483" target="_blank" >10.1016/j.jval.2013.08.483</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
THE ANALYSIS OF COSTS AND REIMBURSEMENTS FOR LUNG CANCER TREATMENT IN THE CZECH REPUBLIC
Popis výsledku v původním jazyce
OBJECTIVES: Lung cancer is the most frequently diagnosed oncologic disease worldwide, annually diagnosed in nearly 1.4 million patients. In 2010, the incidence in men was 89.7 per hundred thousand people (in 1996, it was 102.3), while in women 35.2 (against 22.9 in 1996). The severity of the disease is also reflected by the high mortality rate, which was 74.8 per hundred thousand people in men and 27.4 in women in 2010. METHODS: Identifying the costs spent by a clinic/hospital is difficult in the CzechRepublic, as the majority of hospitals work with cost related data in the ?confidential? mode. The costs were estimated and verified based on expert opinions of pulmonologists, oncologists, head physicians and staff members of technical and economic departments of five pneumo-oncologic centres and university hospitals in this study. RESULTS: Totally 32 procedures (process maps) were identified in lung cancer treatment (10 in diagnostic, 22 in therapeutic processes). Each procedure consis
Název v anglickém jazyce
THE ANALYSIS OF COSTS AND REIMBURSEMENTS FOR LUNG CANCER TREATMENT IN THE CZECH REPUBLIC
Popis výsledku anglicky
OBJECTIVES: Lung cancer is the most frequently diagnosed oncologic disease worldwide, annually diagnosed in nearly 1.4 million patients. In 2010, the incidence in men was 89.7 per hundred thousand people (in 1996, it was 102.3), while in women 35.2 (against 22.9 in 1996). The severity of the disease is also reflected by the high mortality rate, which was 74.8 per hundred thousand people in men and 27.4 in women in 2010. METHODS: Identifying the costs spent by a clinic/hospital is difficult in the CzechRepublic, as the majority of hospitals work with cost related data in the ?confidential? mode. The costs were estimated and verified based on expert opinions of pulmonologists, oncologists, head physicians and staff members of technical and economic departments of five pneumo-oncologic centres and university hospitals in this study. RESULTS: Totally 32 procedures (process maps) were identified in lung cancer treatment (10 in diagnostic, 22 in therapeutic processes). Each procedure consis
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
FQ - Veřejné zdravotnictví, sociální lékařství
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT11532" target="_blank" >NT11532: Hodnocení zdravotnických prostředků</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů